The agency overseeing Medicare and Medicaid proposes $4.5 billion of spending cuts for home healthcare, and new economies on ...

Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for ...

The Dow Jones Industrial Average rose on Tuesday as investors rotated out of technology stocks to kick off the second half of ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...

The tennis pro is teaming up with the medical device giant to launch a global campaign aimed at inspiring people living with ...

Type 2 diabetes (T2D) results from the cells’ insulin resistance, and to date, insulin therapy and diabetes medications targeting glycemic management have failed to reverse the increase in T2D ...

The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with clear health benefits and payer coverage, why has pump adoption been so ...

The global Artificial Pancreas Device Market is projected to be valued at USD 374.3 Million in 2025 and is expected to reach USD 862.0 Million by 2035, registering a CAGR of 8.7%. This market is ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...